TrialThe lancet. Diabetes & endocrinology2024

Once-weekly semaglutide in people with HIV-associated lipohypertrophy: a randomised, double-blind, placebo-controlled phase 2b single-centre clinical trial.

Allison Ross Eckard et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.